Akebia Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AKBA and other ETFs, options, and stocks.About AKBA
Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders.
CEOJohn P. Butler
CEOJohn P. Butler
Employees181
Employees181
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2007
Founded2007
Employees181
Employees181
AKBA Key Statistics
Market cap839.18M
Market cap839.18M
Price-Earnings ratio-17.48
Price-Earnings ratio-17.48
Dividend yield—
Dividend yield—
Average volume2.44M
Average volume2.44M
High today$3.20
High today$3.20
Low today$3.05
Low today$3.05
Open price$3.06
Open price$3.06
Volume2.39M
Volume2.39M
52 Week high$4.08
52 Week high$4.08
52 Week low$1.52
52 Week low$1.52
AKBA News
TipRanks 7h
Akebia Therapeutics’ Pediatric Anemia Study Withdrawn: Market ImplicationsAkebia Therapeutics ((AKBA)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% o...
People also own
Based on the portfolios of people who own AKBA. This list is generated using Robinhood data, and it’s not a recommendation.